PCV112 COST EFFECTIVENESS OF RIVAROXABAN AND DABIGATRAN ETEXILATE FOR THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AND ASSOCIATED LONG TERM COMPLICATIONS POST TOTAL HIP REPLACEMENT IN IRELAND
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74639-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74639-8/fulltext
Title :
PCV112 COST EFFECTIVENESS OF RIVAROXABAN AND DABIGATRAN ETEXILATE FOR THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AND ASSOCIATED LONG TERM COMPLICATIONS POST TOTAL HIP REPLACEMENT IN IRELAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74639-8&doi=10.1016/S1098-3015(10)74639-8
First page :
Section Title :
Open access? :
No
Section Order :
568